PT - JOURNAL ARTICLE AU - Neelon, Brian AU - Mutiso, Fedelis AU - Mueller, Noel T AU - Pearce, John L AU - Benjamin-Neelon, Sara E TI - Associations between governor political affiliation and COVID-19 cases, deaths, and testing in the United States AID - 10.1101/2020.10.08.20209619 DP - 2021 Jan 01 TA - medRxiv PG - 2020.10.08.20209619 4099 - http://medrxiv.org/content/early/2021/01/06/2020.10.08.20209619.short 4100 - http://medrxiv.org/content/early/2021/01/06/2020.10.08.20209619.full AB - Introduction The response to the COVID-19 pandemic became increasingly politicized in the United States (US) and political affiliation of state leaders may contribute to policies affecting the spread of the disease. This study examined differences in COVID-19 infection, death, and testing by governor party affiliation across 50 US states and the District of Columbia.Methods A longitudinal analysis was conducted in December 2020 examining COVID-19 incidence, death, testing, and test positivity rates from March 15 through December 15, 2020. A Bayesian negative binomial model was fit to estimate daily risk ratios (RRs) and posterior intervals (PIs) comparing rates by gubernatorial party affiliation. The analyses adjusted for state population density, rurality, census region, age, race, ethnicity, poverty, number of physicians, obesity, cardiovascular disease, asthma, smoking, and presidential voting in 2020.Results From March to early June, Republican-led states had lower COVID-19 incidence rates compared to Democratic-led states. On June 3, the association reversed, and Republican-led states had higher incidence (RR=1.10, 95% PI=1.01, 1.18). This trend persisted through early December. For death rates, Republican-led states had lower rates early in the pandemic, but higher rates from July 4 (RR=1.18, 95% PI=1.02, 1.31) through mid-December. Republican-led states had higher test positivity rates starting on May 30 (RR=1.70, 95% PI=1.66, 1.73) and lower testing rates by September 30 (RR=0.95, 95% PI=0.90, 0.98).Conclusion Gubernatorial party affiliation may drive policy decisions that impact COVID-19 infections and deaths across the US. Future policy decisions should be guided by public health considerations rather than political ideology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Neelon is a part-time employee of the Department of Veterans Affairs. The content of this article does not represent the views of the Department of Veterans Affairs or the U.S. government. The article represents the views of the authors and not those of the VA or Health Services Research and Development. Dr. Mueller was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K01HL141589 (PI: Mueller).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Boards at the Medical University of South Carolina and Johns Hopkins Bloomberg School of Public Health deemed this research exempt.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this paper are publicly available.